HUTCHMED (China) Ltd

Common Name
HUTCHMED (China)
Country
Hong Kong
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,811
Ticker
13
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the...

HUTCHMED (China)'s Climate Target Data Preview

As of 2023, HUTCHMED (China) has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 intensity-based targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into HUTCHMED (China) ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per US Dollar (USD) of Revenue
Copy restricted. Please purchase to unlock this data.
2025
Intensity-based Target
Scope 3 - Business Travel (Cat. 6)
Metric Tonnes of CO2 equivalent (mtCO2e) per Full Time Equivalent (FTE)
Copy restricted. Please purchase to unlock this data.
2025

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into HUTCHMED (China)'s Greenhouse Gas Emissions Pathways

As of 2023, HUTCHMED (China) has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.

Does HUTCHMED (China) have a target to reduce the emissions from its operations?

As of 2023, HUTCHMED (China) has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

HUTCHMED (China)'s most ambitious operational target is to reduce these emissions by 30% by 2025, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per US Dollar (USD) of Revenue in 2020.

HUTCHMED (China) has already surpassed its operational emissions reduction target, with 2023 levels falling below the 2025 value, achieving its climate goal ahead of schedule.

HUTCHMED (China)'s Operational (Scope 1+2) Emissions Pathway

20202023202500000BaselineCurrent (-68%)Target 2025 (-30%)

Does HUTCHMED (China) have a target to reduce the emissions from its value chain?

As of 2023, HUTCHMED (China) has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.

HUTCHMED (China)'s most ambitious value chain target is to reduce these emissions by 10% by 2025, compared to a baseline of 0.425 Metric Tonnes of CO2 equivalent (mtCO2e) per Full Time Equivalent (FTE) in 2019.

As of 2023, HUTCHMED (China) is lagging behind on its value chain emissions reduction target, having achieved 24% of the planned reduction.

HUTCHMED (China)'s Value Chain (Scope 3) Emissions Pathway

20192023202500.150.30.450.6Current (-2%)
Want Full Access to HUTCHMED (China)'s Climate Targets Dataset?
Sign Up